drugset / Trial / NCT00126100

Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)

NCT00126100 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether stem cell mobilization by granulocyte colony-stimulating factor (G-CSF) therapy in patients with acute myocardial infarction after successful mechanical reperfusion reduces infarct size.

Timeline

Start
2004-02
Primary completion
—
Completion
2005-07

Outcome

Missed primary endpoint

paper in the G-CSF group and 4.9% (8.9%) in the placebo group (P = .56) PMID 16507801 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Granulocyte colony-stimulating factor Protein / enzyme biologic 10 ug/kg Subcutaneous

Indications